A 2-year, post-doctoral position is available in the Guermonprez lab at Institut Pasteur Paris (“Dendritic cells and adaptive immunity” Unit, Immunology Department). The Guermonprez lab investigates the role of dendritic cell subsets in regulating T cell responses and explores novel immunotherapeutic approaches.
There is strong evidence that some populations of CD8+ cells like tissue resident memory-like (TRMs) or poorly differentiated stem-like T cells (TSL) are associated with favorable clinical outcomes and improved responses to immune checkpoint blockade immunotherapies. However, the anti-tumoral function of CD8+ T cells against lung cancer is severely curtailed by immunesuppressive features of the tumor micro-environment including the onset of T cell exhaustion associated to chronic TCR signaling.
CD4+ T cell help can potentially reactivate the generation of anti-tumor CD8+ effectors but this response is somehow impaired.
We are looking for highly motivated individuals willing to bring new insights into the biology of adaptive immunity against cancer and spark innovation in cancer immunotherapy in pre-clinical settings.